Slides from Driving Advances in Liver Health—NASH: Hit the Ground Running

Expert insight on the burden and impact of HBV infection, as well as strategies to overcome barriers to vaccination, from Clinical Care Options (CCO)

Robert G. Gish, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 22, 2022 Expired: March 21, 2023

CCO faculty Manal F. Abdelmalek, MD, MPH, answers FAQs in NASH management including how to incorporate noninvasive biomarkers and treatment options

Manal F. Abdelmalek, MD, MPH Released: January 16, 2020

Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.

Paul Y. Kwo, MD
Program Director Manal F. Abdelmalek, MD, MPH Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ US Physicians: maximum of 1.5 Medical Knowledge MOC point(s) Released: December 17, 2019 Expired: No longer available for credit

Part 1: Hepatitis C (23 mins)

Part 2: Hepatitis B (25 mins)

Part 3: NAFLD/NASH (30 mins)

Part 4: Question and Answer (11 mins)

Downloadable slides on data from AALSD 2019 selected by expert faculty as relevant to care of patients with viral hepatitis or NAFLD/NASH, as reported by Clinical Care Options.

Ira M. Jacobson, MD Nancy Reau, MD Released: December 2, 2019